Total Payments
$11,473
2024 Payments
$2,038
Companies
70
Transactions
490
Medicare Patients
7,302
Medicare Billing
$546,658
Payment Breakdown by Category
Food & Beverage$9,936 (86.6%)
Travel$822.35 (7.2%)
Education$715.06 (6.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,936 | 456 | 86.6% |
| Travel and Lodging | $822.35 | 3 | 7.2% |
| Education | $715.06 | 22 | 6.2% |
| Unspecified | $0 | 9 | 0.0% |
Payments by Type
General
$11,473
481 transactions
Ownership
$0
9 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,822 | 72 | $0 (2024) |
| Boston Scientific Corporation | $1,271 | 21 | $0 (2022) |
| Dendreon Pharmaceuticals LLC | $597.28 | 18 | $0 (2024) |
| Janssen Biotech, Inc. | $588.49 | 29 | $0 (2024) |
| ABBVIE INC. | $576.08 | 30 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $502.73 | 25 | $0 (2024) |
| COLOPLAST CORP | $439.57 | 15 | $0 (2024) |
| PFIZER INC. | $378.06 | 26 | $0 (2022) |
| Teleflex LLC | $357.90 | 9 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $333.59 | 20 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,038 | 81 | Dendreon Pharmaceuticals LLC ($348.34) |
| 2023 | $1,772 | 73 | Astellas Pharma US Inc ($235.11) |
| 2022 | $1,755 | 75 | Astellas Pharma US Inc ($319.69) |
| 2021 | $1,124 | 57 | Astellas Pharma US Inc ($159.66) |
| 2020 | $333.35 | 23 | Zyla Life Sciences, Inc. ($70.48) |
| 2019 | $1,332 | 67 | Astellas Pharma US Inc ($378.41) |
| 2018 | $2,022 | 62 | Boston Scientific Corporation ($1,027) |
| 2017 | $1,097 | 52 | Astellas Pharma US Inc ($298.47) |
All Payment Transactions
490 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Teleflex LLC | — | Food and Beverage | In-kind items and services | $26.31 | General |
| 12/16/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: HORMONE THERAPY | ||||||
| 12/09/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: UROLOGY | ||||||
| 12/05/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: UROLOGY | ||||||
| 12/03/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $28.48 | General |
| 11/25/2024 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | Cash or cash equivalent | $20.57 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: Oncology | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $26.74 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: HORMONE THERAPY | ||||||
| 11/05/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 10/29/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Pain Management | ||||||
| 10/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $26.74 | General |
| Category: Oncology | ||||||
| 10/21/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $25.91 | General |
| Category: Diagnostic Imaging | ||||||
| 10/14/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: Oncology | ||||||
| 10/10/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: UROLOGY | ||||||
| 10/08/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $27.36 | General |
| 10/07/2024 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | Cash or cash equivalent | $21.68 | General |
| Category: ONCOLOGY | ||||||
| 10/03/2024 | Laborie Medical Technologies Corp. | — | Food and Beverage | Cash or cash equivalent | $48.02 | General |
| 10/01/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Oncology | ||||||
| 09/24/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Oncology | ||||||
| 09/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $26.36 | General |
| Category: Oncology | ||||||
| 09/16/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Oncology | ||||||
| 08/28/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: UROLOGY | ||||||
| 08/26/2024 | 180 Medical, Inc. | — | Food and Beverage | In-kind items and services | $28.28 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,947 | 3,232 | $826,050 | $220,731 |
| 2022 | 17 | 1,755 | 2,210 | $375,447 | $95,595 |
| 2021 | 22 | 1,851 | 2,252 | $525,120 | $117,641 |
| 2020 | 20 | 1,749 | 2,150 | $613,340 | $112,691 |
Total Patients
7,302
Total Services
9,844
Medicare Billing
$546,658
Procedure Codes
87
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1952 | Leuprolide injectable, camcevi, 1 mg | Office | 2023 | 11 | 756 | $113,400 | $51,344 | 45.3% |
| 52442 | Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | Office | 2023 | 12 | 53 | $210,940 | $38,818 | 18.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 331 | 442 | $72,046 | $30,048 | 41.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 86 | 102 | $94,860 | $20,476 | 21.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 120 | 147 | $33,516 | $14,739 | 44.0% |
| 52441 | Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | Office | 2023 | 12 | 12 | $62,760 | $12,921 | 20.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 58 | 58 | $15,080 | $6,409 | 42.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 44 | 44 | $13,288 | $5,504 | 41.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 53 | 59 | $10,448 | $4,286 | 41.0% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 12 | 12 | $21,600 | $4,281 | 19.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 22 | 22 | $8,800 | $4,128 | 46.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 50 | 59 | $8,260 | $3,946 | 47.8% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 15 | 15 | $16,950 | $3,877 | 22.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 20 | 53 | $6,812 | $2,798 | 41.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 245 | 334 | $6,680 | $2,785 | 41.7% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 260 | 318 | $31,800 | $2,713 | 8.5% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 21 | 22 | $47,080 | $2,352 | 5.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 16 | 18 | $4,378 | $1,823 | 41.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 13 | $4,212 | $1,818 | 43.2% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 13 | 13 | $7,670 | $1,494 | 19.5% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 228 | 288 | $5,760 | $895.68 | 15.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 19 | 20 | $2,060 | $828.54 | 40.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 237 | 308 | $6,160 | $675.40 | 11.0% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 14 | 22 | $3,520 | $629.42 | 17.9% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 11 | 15 | $2,310 | $595.05 | 25.8% |
About Dr. Thomas Will, M.D
Dr. Thomas Will, M.D is a Urology healthcare provider based in Lagrange, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2008. The National Provider Identifier (NPI) number assigned to this provider is 1891955233.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Will, M.D has received a total of $11,473 in payments from pharmaceutical and medical device companies, with $2,038 received in 2024. These payments were reported across 490 transactions from 70 companies. The most common payment nature is "Food and Beverage" ($9,936).
As a Medicare-enrolled provider, Will has provided services to 7,302 Medicare beneficiaries, totaling 9,844 services with total Medicare billing of $546,658. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Lagrange, IL
- Active Since 06/10/2008
- Last Updated 07/12/2019
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1891955233
Products in Payments
- AMS (Device) $1,055
- XTANDI (Drug) $839.46
- PROVENGE (Drug) $597.28
- Xtandi (Drug) $447.55
- ERLEADA (Drug) $397.40
- XIAFLEX (Biological) $340.74
- LUPRON DEPOT (Drug) $327.11
- Nubeqa (Drug) $266.65
- KEYTRUDA (Biological) $262.54
- TITAN (Device) $258.08
- Myrbetriq (Drug) $255.07
- ELIGARD (Drug) $253.17
- UroLift System (Device) $252.47
- ORGOVYX (Drug) $236.63
- Xofigo (Drug) $236.08
- CAMCEVI (Drug) $179.05
- POSLUMA (Drug) $175.96
- NOCDURNA (Drug) $155.84
- MYRBETRIQ (Drug) $148.81
- PLUVICTO (Drug) $147.89
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.